Association between Beta1-Adrenergic Receptor Polymorphism and Risk of ICD Shock in Heart Failure Patients
Abstract
Background
Sympathetic activation in heart failure patients favors the development of ventricular arrhythmias, thus leading to an increased risk of sudden cardiac death. β1- and β2-adrenergic receptor polymorphisms have been linked to the risk of sudden death. Implantable cardioverter-defibrillators (ICD) are implanted in a large percentage of heart failure patients, and beyond preventing sudden cardiac death they provide a continuous monitoring of major ventricular arrhythmias and of their own interventions. We investigated whether functionally relevant β1- and β2-adrenergic receptor polymorphisms are associated with risk of ICD shocks, as evidenced in ICD memory.
Methods
311 patients with systolic heart failure were enrolled, and number and timing of shocks in ICD memory were recorded. Four selected polymorphisms were determined: β1-adrenergic receptor polymorphisms Ser49Gly and Arg389Gly and β2-adrenergic receptor polymorphisms Arg16Gly and Gln27Glu.
Results
Only Ser49Gly was significantly correlated with time free from ICD shocks, both considering time to the first event in a Cox model (hazard ratio 2.117), and modeling repeated events with the Andersen-Gill method (hazard ratio 2.088). Gly allele carriers had a higher probability of ICD shock. The relationship remained significant even after adjusting for ejection fraction and beta-blocker dosage (hazard ratio 1.910).
Conclusions
Data from our study suggest that the β adrenoreceptor Gly 49 allele of the β1-adrenergic receptor Ser49Gly polymorphisms may increase the risk of ICD shock in patients with heart failure, independent of beta-blocker dosage.
